全文获取类型
收费全文 | 109560篇 |
免费 | 4769篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 1037篇 |
儿科学 | 4015篇 |
妇产科学 | 2798篇 |
基础医学 | 12958篇 |
口腔科学 | 1733篇 |
临床医学 | 13718篇 |
内科学 | 19286篇 |
皮肤病学 | 1090篇 |
神经病学 | 11300篇 |
特种医学 | 3940篇 |
外科学 | 17482篇 |
综合类 | 496篇 |
一般理论 | 109篇 |
预防医学 | 9997篇 |
眼科学 | 2004篇 |
药学 | 5496篇 |
中国医学 | 72篇 |
肿瘤学 | 6877篇 |
出版年
2023年 | 2329篇 |
2022年 | 2781篇 |
2021年 | 3694篇 |
2020年 | 3770篇 |
2019年 | 2652篇 |
2018年 | 2414篇 |
2017年 | 2275篇 |
2016年 | 2201篇 |
2015年 | 2253篇 |
2014年 | 4845篇 |
2013年 | 4920篇 |
2012年 | 4708篇 |
2011年 | 4744篇 |
2010年 | 3939篇 |
2009年 | 3886篇 |
2008年 | 4512篇 |
2007年 | 4707篇 |
2006年 | 4347篇 |
2005年 | 4176篇 |
2004年 | 3823篇 |
2003年 | 3866篇 |
2002年 | 3658篇 |
2001年 | 3636篇 |
2000年 | 3501篇 |
1999年 | 3476篇 |
1998年 | 1215篇 |
1997年 | 897篇 |
1996年 | 774篇 |
1995年 | 719篇 |
1994年 | 624篇 |
1993年 | 651篇 |
1992年 | 2575篇 |
1991年 | 2496篇 |
1990年 | 2328篇 |
1989年 | 2093篇 |
1988年 | 2008篇 |
1987年 | 991篇 |
1986年 | 337篇 |
1985年 | 623篇 |
1984年 | 592篇 |
1983年 | 541篇 |
1982年 | 479篇 |
1981年 | 434篇 |
1980年 | 407篇 |
1979年 | 383篇 |
1978年 | 383篇 |
1977年 | 283篇 |
1976年 | 277篇 |
1975年 | 219篇 |
1973年 | 221篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《Survey of ophthalmology》2023,68(5):920-928
There remains limited agreement regarding the efficacy and safety of different antivascular endothelial growth factor (anti-VEGF) agents for the management of polypoidal choroidal vasculopathy (PCV). Our meta-analysis compares different anti-VEGF agents for PCV treatment. Ovid MEDLINE, EMBASE, and Cochrane Library were systematically searched from January 2000 to July 2022. We included articles comparing the efficacy and safety of different anti-VEGF agents, specifically bevacizumab (BEV), ranibizumab (RAN), aflibercept AFL), and brolucizumab (BRO), for patients with PCV. 10,440 studies were identified, 122 underwent full-text review, and seven were included. One study was a randomized trial, and six were observational studies. Ranibizumab and aflibercept were associated with a similar best-corrected visual acuity (BCVA) at the last visit in three observational studies (P = 0.10), similar retinal thickness at the last visit in two observational studies (P = 0.85). One observational study comparing BEV versus RAN found comparable outcomes for final BCVA, retinal thickness, and polyp regression. One randomized trial on BRO versus AFL found comparable outcomes for improvement in BCVA, while anatomical outcomes favored BRO. The available evidence suggests that final BCVA is comparable across different anti-VEGF agents, however, further investigation is warranted due to paucity of evidence. 相似文献
2.
3.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):301-326
ObjectiveThe use of mechanical circulatory support (MCS) in lung transplantation has been steadily increasing over the prior decade, with evolving strategies for incorporating support in the preoperative, intraoperative, and postoperative settings. There is significant practice variability in the use of these techniques, however, and relatively limited data to help establish institutional protocols. The objective of the AATS Clinical Practice Standards Committee (CPSC) expert panel was to review the existing literature and establish recommendations about the use of MCS before, during, and after lung transplantation.MethodsThe AATS CPSC assembled an expert panel of 16 lung transplantation physicians who developed a consensus document of recommendations. The panel was broken into subgroups focused on preoperative, intraoperative, and postoperative support, and each subgroup performed a focused literature review. These subgroups formulated recommendation statements for each subtopic, which were evaluated by the entire group. The statements were then developed via discussion among the panel and refined until consensus was achieved on each statement.ResultsThe expert panel achieved consensus on 36 recommendations for how and when to use MCS in lung transplantation. These recommendations included the use of veno-venous extracorporeal membrane oxygenation (ECMO) as a bridging strategy in the preoperative setting, a preference for central veno-arterial ECMO over traditional cardiopulmonary bypass during the transplantation procedure, and the benefit of supporting selected patients with MCS postoperatively.ConclusionsAchieving optimal results in lung transplantation requires the use of a wide range of strategies. MCS provides an important mechanism for helping these critically ill patients through the peritransplantation period. Despite the complex nature of the decision making process in the treatment of these patients, the expert panel was able to achieve consensus on 36 recommendations. These recommendations should provide guidance for professionals involved in the care of end-stage lung disease patients considered for transplantation. 相似文献
4.
5.
《The Canadian journal of cardiology》2022,38(10):1634-1640
BackgroundDatabases for Congenital Heart Disease (CHD) are effective in delivering accessible datasets ready for statistical inference. Data collection hitherto has, however, been labour and time intensive and has required substantial financial support to ensure sustainability. We propose here creation and piloting of a semiautomated technique for data extraction from clinic letters to populate a clinical database.MethodsPDF formatted clinic letters stored in a local folder, through a series of algorithms, underwent data extraction, preprocessing, and analysis. Specific patient information (diagnoses, diagnostic complexity, interventions, arrhythmia, medications, and demographic data) was processed into text files and structured data tables, used to populate a database. A specific data validation schema was predefined to verify and accommodate the information populating the database. Unsupervised learning in the form of a dimensionality reduction technique was used to project data into 2 dimensions and visualize their intrinsic structure in relation to the diagnosis, medication, intervention, and European Society of Cardiology classification lists of disease complexity. Ninety-three randomly selected letters were reviewed manually for accuracy.ResultsThere were 1409 consecutive outpatient clinic letters used to populate the Scottish Adult Congenital Cardiac Database. Mean patient age was 35.4 years; 47.6% female; with 698 (49.5%) having moderately complex, 369 (26.1%) greatly complex, and 284 (20.1%) mildly complex lesions. Individual diagnoses were successfully extracted in 96.95%, and demographic data were extracted in 100% of letters. Data extraction, database upload, data analysis and visualization took 571 seconds (9.51 minutes). Manual data extraction in the categories of diagnoses, intervention, and medications yielded accuracy of the computer algorithm in 94%, 93%, and 93%, respectively.ConclusionsSemiautomated data extraction from clinic letters into a database can be achieved successfully with a high degree of accuracy and efficiency. 相似文献
6.
《The journal of pain》2022,23(9):1604-1615
With the advent of platinum and taxane compounds used as single agents or in combination regimens, survival rates for some of the most common cancers have improved substantially. However, information on differences in the chemotherapy-induced peripheral neuropathy (CIPN) phenotype among single and combination regimens is limited. Study's purposes were to evaluate for differences in demographic and clinical characteristics; subjective and objective measures of CIPN; as well as the severity of common symptoms and quality of life among survivors who received platinum- (n = 95), taxane- (n = 200), or platinum and taxane-containing (n = 131) regimens. Patients completed self-report questionnaires (ie, duration of CIPN, pain intensity, pain qualities, pain interference) and underwent a physical examination that evaluated light touch, pain, and cold sensations and balance. For most of the subjective and objective measures of CIPN, as well as symptom severity and quality of life scores, no differences were found among the 3 chemotherapy groups. In all 3 chemotherapy treatment groups, CIPN was a painful, small fiber, and length dependent neuropathy. These findings support the hypothesis that CIPN induced by different classes of chemotherapy, as single agents or in combination, produce a similar CIPN phenotype which raises the possibility that CIPN induced by diverse chemotherapy protocols has the same underlying mechanism.PerspectiveIn this study, that compared patients who received only platinum, only taxane, or both platinum and taxane containing regimens, no differences were found among the 3 groups in the CIPN phenotype. Findings raise the possibility that CIPN induced by diverse chemotherapy protocols has the same underlying mechanism. 相似文献
7.
8.
9.
10.